Our criticism of a high risk, speculative drug experiment conducted on healthy children and adolescents at Yale University’s Psychiatric Institute was validated by a federal investigation: and our criticism is now validated by the principle investigator, Dr. Thomas McGlashan.
The Washington Post reveals that a shocking secret investigative report by a Nigerian government panel of medical experts concluded that Pfizer Pharmaceuticals conducted an unethical drug experiment in Nigeria in 1996.
When the Times refers to an experiment as "bold and controversial" the reporter is sanitizing the fact that the experiment is UNETHICAL—it violates medicine’s cardinal rule "First, do no harm."
A BBC documentary that airs Thursday, April 27 exposes the disregard for the welfare of patients exploited by US pharmaceutical companies that outsource their clinical drug trials to India, the drug industry’s current favorite drug testing laboratory.
"Risks of anaphylaxis applies to all studies at PAREXEL, with drugs at every stage of development, and the staff are well trained in anticipation of this (unlikely) possibility.
A front page report in The New York Times provides additonal information about the catastrophic TGN1412 medical experiment in which 6 previously healthy volunteers were intravenously injected with monoclonal antibody in a highly risky procedure.
The independent Institute of Science in Society (ISIS) challenges the report issued by the UK government medicines oversight agency, MHRA (equivalent to US FDA), absolving itself and those involved from any responsibility for a catastrophic human experiment that nearly killed six healthy volunteers.
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has released an interim report about the near fatal clinical trial of the monoclonal antibody, TGN1412, stating:
Psychiatry’s professional practice paradigm has received a major blow.
“Medication-Free Research in Early Episode Schizophrenia: Evidence of Long-Term Harm?” An article in the Schizophrenia Bulletin, by Dr. John Bola that dares to question the validity of the unexamined treatment paradigm in schizophrenia:
"That thing I’m worried about…where the MedGuide would help, where it might even warrant a black box, if this is common, where somebody hallucinates and then gets put on an anti-psychotic drug. That would really be something worth making sure it doesn’t happen,"
AHRP Urges Actions to Minimize Risks for Children prescribed psychotropic drugs: Action is needed to protect children from widespread prescribing of psychoactive drugs for ill-defined behavioral symptoms.
